Back to VANGUARD GROUP INC VANGUARD GROUP INC

GALTGALT
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in GALECTIN THERAPEUTICS INC

VANGUARD GROUP INC holds 2.3M shares of GALT (GALECTIN THERAPEUTICS INC), worth $9.5M as of 2025-Q4. The position was increased (+1.8% shares). GALT represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$9.5M

Current Shares

2.3M

Total Value Change

+$3.7M

Total Shares Change

+154,643

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
2.3M
+1.8%
$9.5M0.0%$4.08
28
2025-Q3
Increased
2.2M
+2.9%
$9.5M0.0%$4.22
28
2025-Q2
Decreased
2.2M
-0.4%
$4.6M0.0%$2.33
0
2025-Q1
Increased
2.2M
+2.6%
$2.7M0.0%$1.52
18
2024-Q4
Increased
2.1M
+0.2%
$2.8M0.0%$1.10
18
2024-Q3
New
2.1M
-
$5.9M0.0%$2.71
38

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, OSAIC HOLDINGS, INC., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used